M Salcedo
Overview
Explore the profile of M Salcedo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salcedo M, Alain T, Lacoux C, Jones J, Della Vecchia C, Charpentier N, et al.
J Int Assoc Provid AIDS Care
. 2025 Mar;
24:23259582251320127.
PMID: 40025868
In 2020, people living with HIV (PLHIV) in France were worried that the COVID-19 health crisis would lead to long-term changes in their HIV care. Using data from the anonymous,...
2.
Bandala C, De la Garza-Montano P, Cortes-Algara A, Cruz-Lopez J, Dominguez-Rubio R, Gonzalez-Lopez J, et al.
Asian Pac J Cancer Prev
. 2016 Jan;
16(18):8397-403.
PMID: 26745092
Background: Breast cancer (BCa) is the most common malignancy in Mexican women. A set of histopathological markers has been established to guide BCa diagnosis, prognosis and treatment. Nevertheless, in only...
3.
Valerio M, Munoz P, Rodriguez C, Caliz B, Padilla B, Fernandez-Cruz A, et al.
Clin Microbiol Infect
. 2015 Mar;
21(5):492.e1-9.
PMID: 25748494
Antifungal stewardship (AFS) programmes are needed in tertiary-care hospitals. Our aim is to describe a bedside non-restrictive AFS programme, and to evaluate its economic impact. During the first year of...
4.
Ortega F, Puig J, Paul-Ramos F, Salcedo M, Bravo J, de la Cruz J, et al.
Transplant Proc
. 2014 Dec;
46(10):3629-36.
PMID: 25498101
A significant proportion of transplant patients undergoing immunosuppressant therapy experience gastrointestinal (GI) symptoms. The SIGIT-QoL is a brief instrument developed to measure adverse gastrointestinal effects on patients' health-related quality of...
5.
Rivera F, Massuti B, Salcedo M, Sastre J, Martinez Galan J, Valladares-Ayerbes M, et al.
Cancer Chemother Pharmacol
. 2014 Dec;
75(2):319-24.
PMID: 25491381
Purpose: Chemotherapy has improved the overall survival (OS) in patients (pts) with advanced gastric cancer (AGC). Docetaxel (D), oxaliplatin (O) and capecitabine (C) have shown interesting activity in this setting....
6.
Banares R, Salcedo M
Transplant Proc
. 2014 Nov;
46(9):3095-6.
PMID: 25420832
Liver transplantation has rapidly evolved from an almost experimental procedure to a widely accepted and validated therapeutic tool for the management of terminal liver diseases. Survival after OLT has significantly...
7.
Moraleda L, Albinana J, Salcedo M, Gonzalez-Moran G
Rev Esp Cir Ortop Traumatol
. 2013 Apr;
57(1):67-77.
PMID: 23594985
Developmental dysplasia of the hip (DDH) causes anatomical changes that cause early coxarthrosis. Although risf factors have been determined, the aetiology and physiopathology remains exactly unknown. Neonatal screening with physical...
8.
Tasset I, Aguera E, Gascon F, Giraldo A, Salcedo M, Cruz A, et al.
Rev Neurol
. 2012 Apr;
54(8):449-52.
PMID: 22492096
Introduction: The sensitivity of the central nervous system to oxidative damage and its relationship with inflammatory response are well known. Recent studies have shown that oxidative stress is present in...
9.
Cedres S, Montero M, Martinez P, Martinez A, Rodriguez-Freixinos V, Torrejon D, et al.
Lung Cancer
. 2012 Mar;
77(1):192-8.
PMID: 22459204
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive neoplasm with elevated AKT/mTOR activity. We aimed to identify the expression and phosphorylation status of PTEN, PI3K and downstream signaling in...
10.
Pacheco-Rivera R, Hernandez-Zamora E, Gonzalez-Yebra B, Beattie K, Maldonado-Rodriguez R, Santiago-Hernandez J, et al.
Clin Exp Med
. 2011 Jan;
11(4):227-34.
PMID: 21253810
The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene...